Kamat Pharmatech
Kamat Pharmatech is a US-based pharmaceutical contract development organization specializing in formulation development, regulatory strategy, and the advancement of complex generics, injectable, lyophilized, oral liquid, and topical drug products. With over a decade of experience and scientific leadership in lyophilization, injectables, topicals, and regulatory pathways, the company serves as a partner for pharmaceutical firms seeking expertise in development, characterization, and US-FDA compliance.
Kamat Pharmatech
685 US Highway 1, North Brunswick, NJ 08902
What We Do
Formulation and process development for injectable pharmaceuticals, including complex injectables.
Product and process development, as well as technical training for lyophilization in pharmaceuticals.
Development of complex generic products including injectables, oral liquids, and topicals.
Development and regulatory support for products submitted through the 505(b)(2) pathway.
Analytical services for in vitro release testing (IVRT) of pharmaceutical products.
Industry-focused training on lyophilization technology for pharmaceutical professionals and organizations.
Key People
News & Updates
Successful product launch resulting in significant US market share for this oral suspension.
Successful development and commercialization of a 505(b)(2) regulatory pathway oral solution product in the United States.
Preparing regulatory filings and launching five new unique pharmaceutical products within the next 1–2 years.